MinichMacGregor Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $367K | Buy |
1,456
+1
| +0.1% | +$215 | 0.06% | 101 |
|
|
2026
Q1 | $317K | Sell |
1,455
-383
| -21% | -$85K | 0.06% | 95 |
|
|
2025
Q4 | $420K | Sell |
1,838
-462
| -20% | -$105K | 0.08% | 80 |
|
|
2025
Q3 | $532K | Sell |
2,300
-3
| -0.1% | -$611 | 0.1% | 75 |
|
|
2025
Q2 | $427K | Sell |
2,303
-563
| -20% | -$105K | 0.09% | 77 |
|
|
2025
Q1 | $600K | Buy |
2,866
+335
| +13% | +$65.1K | 0.13% | 62 |
|
|
2024
Q4 | $450K | Buy |
2,531
+840
| +50% | +$154K | 0.09% | 72 |
|
|
2024
Q3 | $334K | Sell |
1,691
-14
| -0.8% | -$2.61K | 0.07% | 84 |
|
|
2024
Q2 | $292K | Buy |
1,705
+6
| +0.4% | +$994 | 0.07% | 87 |
|
|
2024
Q1 | $307K | Buy |
1,699
+113
| +7% | +$19.5K | 0.08% | 84 |
|
|
2023
Q4 | $246K | Sell |
1,586
-24,656
| -94% | -$3.59M | 0.07% | 90 |
|
|
2023
Q3 | $3.91M | Buy |
26,242
+2,929
| +13% | +$430K | 1.3% | 24 |
|
|
2023
Q2 | $3.14M | Buy |
23,313
+4,974
| +27% | +$729K | 0.98% | 36 |
|
|
2023
Q1 | $2.92M | Buy |
18,339
+4,062
| +28% | +$621K | 0.97% | 30 |
|
|
2022
Q4 | $2.31M | Buy |
14,277
+456
| +3% | +$69.9K | 0.83% | 24 |
|
|
2022
Q3 | $1.85M | Buy |
13,821
+11,825
| +592% | +$1.7M | 0.74% | 31 |
|
|
2022
Q2 | $305K | Sell |
1,996
-194
| -9% | -$29.6K | 0.13% | 55 |
|
|
2022
Q1 | $355K | Buy |
2,190
+574
| +36% | +$83.4K | 0.11% | 70 |
|
|
2021
Q4 | $218K | Buy |
+1,616
| New | +$191K | 0.07% | 80 |
|
|
2020
Q3 | – | Sell |
-2,052
| Closed | -$201K | – | 63 |
|
|
2020
Q2 | $201K | Sell |
2,052
-17,367
| -89% | -$1.53M | 0.11% | 57 |
|
|
2020
Q1 | $1.59M | Buy |
19,419
+16,121
| +489% | +$1.37M | 1.43% | 13 |
|
|
2019
Q4 | $292K | Buy |
+3,298
| New | +$274K | 0.16% | 46 |
|
|
2019
Q1 | – | Sell |
-4,614
| Closed | -$410K | – | 48 |
|
|
2018
Q4 | $410K | Buy |
4,614
+2,691
| +140% | +$237K | 0.28% | 72 |
|
|
2018
Q3 | $182K | Hold |
1,923
| – | – | 0.12% | 45 |
|
|
2018
Q2 | $179K | Sell |
1,923
-200
| -9% | -$19.5K | 0.13% | 47 |
|
|
2018
Q1 | $200K | Sell |
2,123
-911
| -30% | -$100K | 0.16% | 40 |
|
|
2017
Q4 | $293K | Sell |
3,034
-1
| -0% | -$94 | 0.23% | 33 |
|
|
2017
Q3 | $269K | Sell |
3,035
-75
| -2% | -$5.71K | 0.22% | 32 |
|
|
2017
Q2 | $225K | Buy |
3,110
+1,272
| +69% | +$85.5K | 0.2% | 35 |
|
|
2017
Q1 | $119K | Hold |
1,838
| – | – | 0.11% | 52 |
|
|
2016
Q4 | $115K | Sell |
1,838
-84
| -4% | -$5.13K | 0.11% | 55 |
|
|
2016
Q3 | $121K | Hold |
1,922
| – | – | 0.11% | 52 |
|
|
2016
Q2 | $118K | Hold |
1,922
| – | – | 0.11% | 53 |
|
|
2016
Q1 | $109K | Sell |
1,922
-81
| -4% | -$4.51K | 0.11% | 55 |
|
|
2015
Q4 | $133K | Buy |
+2,003
| New | +$115K | 0.12% | 50 |
|
Other funds holding ABBV
ECSS
ATO
MinichMacGregor Wealth Management's ABBV Position: Q2 2026 in Review
MinichMacGregor Wealth Management increased its AbbVie (ABBV) stake by 0.07% in Q2 2026, buying an estimated $215 and bringing the position to 1,456 shares worth $367K. The position accounts for 0.06% of the portfolio, ranked #101.
MinichMacGregor Wealth Management first reported a position in ABBV in Q4 2015 and has held it in 35 quarters since. The position peaked at $3.91M in Q3 2023. 2,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- MinichMacGregor Wealth Management held 1,456 shares of AbbVie worth $367K as of Q2 2026.
- MinichMacGregor Wealth Management bought 1 AbbVie share in Q2 2026, an estimated $215.
- AbbVie made up 0.06% of MinichMacGregor Wealth Management's portfolio in Q2 2026, its #101 holding.
- MinichMacGregor Wealth Management first reported a position in AbbVie in Q4 2015 and has held it in 35 quarters since.
- MinichMacGregor Wealth Management's AbbVie position peaked at $3.91M in Q3 2023.
- 2,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on MinichMacGregor Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.